Clinic
Planned Parenthood Mar Monte, INC
Planned Parenthood Mar Monte, INC was paid $5.69M by Medicaid between Jan 2018 and Dec 2024, across 69 billing codes. Its largest line is 99213, doctor's office visit, returning patient (routine) — 12% of everything it billed.
33Billing provider infoPLANNED PARENTHOOD MAR MONTE, INC
FRESNO, CA 93710
FRESNO, CA 93710
33aNPI1023062593assigned 05/20/2006
33bProvider typeCommunity Health Clinic/Center
28Total paid$5.69M
24GClaims230,072
24DCodes billed69
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other Community Health Clinic/Center providers in California
Rank by total paid#71 of 288
Median peer was paid$2.15M
This provider vs. median2.6×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Auditor's notes
Automated statistical signals. Not evidence of fraud — how these are computed.
Entity ProliferationAuthorized official MOTSIFF, TOM controls 20+ related entities in our dataset. Read more
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 63,235 | $1.61M | |
| 2019 | 36,168 | $801K | |
| 2020 | 15,816 | $339K | |
| 2021 | 29,507 | $958K | |
| 2022 | 29,799 | $724K | |
| 2023 | 20,126 | $482K | |
| 2024incomplete | 35,421 | $785K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 12% | 17,042 | 15,468 | $708K |
| J7307 | Etonogestrel (contraceptive) implant system, including implant and supplies | 12% | 1,320 | 1,316 | $671K |
| S4993 | Contraceptive pills for birth control | 10% | 8,522 | 7,989 | $573K |
| J3490 | Unclassified drugs | 9.6% | 34,229 | 25,859 | $545K |
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | 8.2% | 22,249 | 19,993 | $464K |
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 7.2% | 9,041 | 8,191 | $411K |
| 99202 | Office or other outpatient visit for the evaluation and management of a new patient, straightforward | 6.3% | 4,297 | 4,196 | $359K |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | 5.8% | 9,327 | 8,740 | $329K |
| 99201 | 4.0% | 4,205 | 3,841 | $230K | |
| 99203 | Doctor's office visit, new patient (routine)Office or other outpatient visit for the evaluation and management of a new patient, low complexity | 3.7% | 1,514 | 1,513 | $212K |
| S0199 | Medically induced abortion by oral ingestion of medication including all associated services and supplies (e.g., patient counseling, office visits, confirmation of pregnancy by hcg, ultrasound to confirm duration of pregnancy, ultrasound to confirm completion of abortion) except drugs | 3.2% | 2,083 | 2,051 | $185K |
| 11981 | 3.0% | 1,219 | 1,215 | $169K |
57 more codes
| 87806 | 2.9% | 13,349 | $164K | |
| A4267 | Contraceptive supply, condom, male, each | 1.9% | 14,930 | $110K |
| 58300 | 1.1% | 874 | $61K | |
| 99204 | Doctor's office visit, new patient (more involved) | <1% | 390 | $55K |
| 11976 | <1% | 1,194 | $51K | |
| 87661 | Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe | <1% | 3,209 | $47K |
| J7304 | Contraceptive supply, hormone containing patch, each | <1% | 74 | $47K |
| S9445 | Patient education, not otherwise classified, non-physician provider, individual, per session | <1% | 3,401 | $43K |
| 99402 | <1% | 772 | $24K | |
| S5000 | Prescription drug, generic | <1% | 3,604 | $24K |
| S0190 | Mifepristone, oral, 200 mg | <1% | 2,075 | $22K |
| J7298 | Levonorgestrel-releasing intrauterine contraceptive system (mirena), 52 mg | <1% | 39 | $19K |
| 99401 | <1% | 1,131 | $18K | |
| 99000 | <1% | 10,109 | $18K | |
| 81025 | <1% | 14,176 | $17K | |
| 76815 | Ultrasound, pregnant uterus, real time with image documentation, limited | <1% | 1,879 | $16K |
| Q0111 | Wet mounts, including preparations of vaginal, cervical or skin specimens | <1% | 9,670 | $13K |
| J7303 | Contraceptive supply, hormone containing vaginal ring, each | <1% | 90 | $13K |
| J7300 | Intrauterine copper contraceptive (paragard) | <1% | 26 | $12K |
| 83986 | <1% | 8,507 | $11K | |
| Q3014 | Telehealth originating site facility fee | <1% | 854 | $10K |
| 99403 | <1% | 132 | $6K | |
| 58301 | <1% | 377 | $6K | |
| Q0144 | Azithromycin dihydrate, oral, capsules/powder, 1 gram | <1% | 2,979 | $5K |
| 0270 | <1% | 4,827 | $4K | |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | <1% | 838 | $3K |
| G2012 | Brief communication technology-based service, e.g. virtual check-in, by a physician or other qualified health care professional who can report evaluation and management services, provided to an established patient, not originating from a related e/m service provided within the previous 7 days nor leading to an e/m service or procedure within the next 24 hours or soonest available appointment; 5-10 minutes of medical discussion | <1% | 423 | $2K |
| 99395 | Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years | <1% | 195 | $2K |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | <1% | 3,163 | $2K |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | <1% | 2,565 | $2K |
| 81002 | <1% | 2,156 | $2K | |
| Z6406 | <1% | 140 | $1K | |
| T1014 | Telehealth transmission, per minute, professional services bill separately | <1% | 778 | $1K |
| 11982 | <1% | 228 | $1K | |
| 85018 | <1% | 1,139 | $962.88 | |
| S0191 | Misoprostol, oral, 200 mcg | <1% | 2,111 | $934.05 |
| Z6410 | <1% | 106 | $827.47 | |
| 76817 | Ultrasound, pregnant uterus, real time with image documentation, transvaginal | <1% | 12 | $661.23 |
| J8499 | Prescription drug, oral, non chemotherapeutic, nos | <1% | 175 | $604.24 |
| Z7610 | <1% | 26 | $245.39 | |
| 90715 | <1% | 15 | $145.01 | |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 70 | $100.38 |
| 90686 | <1% | 167 | $70.24 | |
| 90688 | <1% | 13 | $44.60 | |
| 99070 | <1% | 754 | $33.80 | |
| 86901 | <1% | 153 | $22.14 | |
| 82948 | 0% | 14 | $0.00 | |
| 59425 | 0% | 67 | $0.00 | |
| H1003 | Prenatal care, at-risk enhanced service; education | 0% | 90 | $0.00 |
| 3078F | 0% | 15 | $0.00 | |
| H1001 | Prenatal care, at-risk enhanced service; antepartum management | 0% | 79 | $0.00 |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | 0% | 314 | $0.00 |
| 1220F | 0% | 340 | $0.00 | |
| 0250 | 0% | 14 | $0.00 | |
| 3074F | 0% | 74 | $0.00 | |
| 3079F | 0% | 17 | $0.00 | |
| 3351F | 0% | 105 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialMOTSIFF, TOM (CFO)
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.